XML 35 R22.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Apr. 19, 2021
Feb. 08, 2021
Feb. 03, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]              
Reverse stock split one-for-fifteen reverse stock split of its common stock            
Common stock, par value $ 0.0001       $ 0.0001   $ 0.0001
Class of Warrant or Right, Number of Securities Called by Warrants or Rights         1,794,156    
Common stock, shares outstanding         7,914,339   3,284,322
Capital stock shares authorized         155,000,000    
Capital stock par value         $ 0.0001    
Common stock shares authorized         150,000,000   150,000,000
Share-based Payment Arrangement, Option [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock option granted         78,678    
Stock option vesting period         3 years    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate         0.00%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum         129.12%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum         136.78%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum         0.59%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum         1.17%    
Fair value of stock options         $ 477,243    
Series F And G Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of issuance of public offering         1,225,412    
Proceeds from sale of stock         $ 9,469,000    
Series C Convertible Preferred Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Preferred stock issued upon conversion         625    
Common stock, shares outstanding         1,718    
Securities Purchase Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of issuance of public offering     89,445        
Shares Issued, Price Per Share     $ 10.062        
Proceeds from sale of stock     $ 900,000        
Maximum [Member] | Share-based Payment Arrangement, Option [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock option granted, exercise price         $ 10.05    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term         6 years 6 months    
Maximum [Member] | Series F And G Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants exercise price         $ 10.23    
Minimum [Member] | Share-based Payment Arrangement, Option [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock option granted, exercise price         $ 5.04    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term         5 years 6 months    
Minimum [Member] | Series F And G Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants exercise price         $ 7.425    
Underwriter Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares Issued, Price Per Share   $ 10.23          
Warrants and Rights Outstanding, Term   5 years          
Underwriter Warrants [Member] | Maximum [Member]              
Subsidiary, Sale of Stock [Line Items]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   111,290          
Series G Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Issuance of common shares, warrants, pre-funded warrants and exercise of pre-funded warrants, net of issuance costs, shares   145,161          
Shares Issued, Price Per Share   $ 10.23          
Warrants and Rights Outstanding, Term   5 years          
Series B Convertible Preferred Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Conversion of series b convertible preferred stock to common shares, shares         17,303    
Conversion of series b convertible preferred stock to common shares, shares         (17,303)    
Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of issuance of public offering       731,273   731,273  
Conversion of series b convertible preferred stock to common shares, shares         (207,528)    
Conversion of series b convertible preferred stock to common shares, shares         207,528    
Conversion of series c convertible preferred stock to common shares, shares         831    
Common Stock [Member] | Series C Convertible Preferred Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Conversion of series c convertible preferred stock to common shares, shares         2,280    
Preferred Stock Blank Check [Member]              
Subsidiary, Sale of Stock [Line Items]              
Preferred stock shares authorized         5,000,000    
Underwritten Public Offering [Member]              
Subsidiary, Sale of Stock [Line Items]              
Common stock, par value   $ 0.0001          
Number of issuance of public offering   1,935,484          
Shares Issued, Price Per Share   $ 9.30          
Over-Allotment Option [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of issuance of public offering   290,322          
Net proceeds from issuance of stock   $ 18,900,000          
At The Market Offering [Member]              
Subsidiary, Sale of Stock [Line Items]              
Sale of Stock, Number of Shares Issued in Transaction         818,523    
Sale of Stock, Consideration Received on Transaction         $ 5,659,000    
Employee Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock option vesting period         3 years    
Number of restricted stock shares granted         21,042    
Fair value of restricted stock granted         $ 138,776